1.Impact of Tumor Location on the Quality of Life of Patients Undergoing Total or Proximal Gastrectomy
Muneharu FUJISAKI ; Takashi NOMURA ; Hiroharu YAMASHITA ; Yoshikazu UENOSONO ; Tetsu FUKUNAGA ; Eigo OTSUJI ; Masahiro TAKAHASHI ; Hideo MATSUMOTO ; Atsushi OSHIO ; Koji NAKADA
Journal of Gastric Cancer 2022;22(3):235-247
Purpose:
Most studies have investigated the differences in postgastrectomy quality of life (QOL) based on the surgical procedure or reconstruction method adopted; only a few studies have compared QOL based on tumor location. This large-scale study aims to investigate the differences in QOL between patients with esophagogastric junction cancer (EGJC) and those with upper third gastric cancer (UGC) undergoing the same gastrectomy procedure to evaluate the impact of tumor location on postoperative QOL.
Methods:
The Postgastrectomy Syndrome Assessment Scale-45 (PGSAS-45) questionnaire was distributed in 70 institutions to 2,364 patients who underwent gastrectomy for EGJC or UGC.A total of 1,909 patients were eligible for the study, and 1,744 patients who underwent total gastrectomy (TG) or proximal gastrectomy (PG) were selected for the final analysis. These patients were divided into EGJC and UGC groups; thereafter, the PGSAS-45 main outcome measures (MOMs) were compared between the two groups for each type of gastrectomy.
Results:
Among the post-TG patients, only one MOM was significantly better in the UGC group than in the EGJC group. Conversely, among the post-PG patients, postoperative QOL was significantly better in 6 out of 19 MOMs in the UGC group than in the EGJC group.
Conclusions
Tumor location had a minimal effect on the postoperative QOL of post-TG patients, whereas among post-PG patients, there were definite differences in postoperative QOL between the two groups. It seems reasonable to conservatively estimate the benefits of PG in patients with EGJC compared to those in patients with UGC.
2.A Case of Sudden Onset Septicemia in Recurred Gastric Cancer Following S1 Plus Docetaxel Treatment.
Sumiya ISHIGAMI ; Takaaki ARIGAMI ; Yoshikazu UENOSONO ; Yasuto UCHIKADO ; Yoshiaki KITA ; Ken SASAKI ; Hiroshi OKUMURA ; Hiroshi KURAHARA ; Yuko KIJIMA ; Akihiro NAKAJO ; Kosei MAEMURA ; Shoji NATSUGOE
Journal of Gastric Cancer 2013;13(2):126-128
Pyogenic liver abscess in patients with malignant disease is a fatal state and is easily diagnosed. We presented a rare case of sudden fatal septicemia following anticancer treatment for recurred gastric cancer due to multiple liver abscesses which could not be diagnosed. A 72-year-old male with recurred gastric cancer received anticancer agents. He had a history of distal gastrectomy with right hepatic lobectomy for hepatic metastasis. He received anticancer treatment in the outpatient's service center periodically, and his performance status was preserved with nothing in particular. After administrating docetaxel, he suddenly developed septicemia and multiple organ failure and died 5 days after strong medical supports. Pathological autopsy revealed that multiple minute abscesses of the liver which could not be detected macroscopically were the causes of fatal septicemia. The etiology, therapies and prognosis of rare entity are being discussed.
Abscess
;
Antineoplastic Agents
;
Autopsy
;
Gastrectomy
;
Hepatectomy
;
Humans
;
Liver
;
Liver Abscess
;
Liver Abscess, Pyogenic
;
Male
;
Multiple Organ Failure
;
Neoplasm Metastasis
;
Prognosis
;
Sepsis
;
Stomach Neoplasms
;
Taxoids